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The biogenesis of cytochrome c oxidase initiates with synthesis and maturation of the mitochondrion-
encoded Cox1 subunit prior to the addition of other subunits. Cox1 contains redox cofactors, including the
low-spin heme a center and the heterobimetallic heme a3:CuB center. We sought to identify the step in the
maturation of Cox1 in which the redox cofactor centers are assembled. Newly synthesized Cox1 is incorporated
within one early assembly intermediate containing Mss51 in Saccharomyces cerevisiae. Subsequent Cox1 mat-
uration involves the progression to downstream assembly intermediates involving Coa1 and Shy1. We show
that the two heme a cofactor sites in Cox1 form downstream of Mss51- and Coa1-containing Cox1 interme-
diates. These Cox1 intermediates form normally in cells defective in heme a biosynthesis or in cox1 mutant
strains with heme a axial His mutations. In contrast, the Shy1-containing Cox1 assembly intermediate is
perturbed in the absence of heme a. Heme a3 center formation in Cox1 appears to be chaperoned by Shy1. CuB
site formation occurs near or at the Shy1-containing Cox1 assembly intermediate also. The CuB metallochap-
erone Cox11 transiently interacts with Shy1 by coimmunoprecipitation. The Shy1-containing Cox1 complex is
markedly attenuated in cells lacking Cox11 but is partially restored with a nonfunctional Cox11 mutant. Thus,
formation of the heterobimetallic CuB:heme a3 site likely occurs in the Shy1-containing Cox1 complex.
Cytochrome c oxidase (CcO) is the terminal oxidase in the
oxidative phosphorylation chain within mitochondria. Mam-
malian CcO is a 13-subunit complex in which three mitochon-
drion-encoded subunits (Cox1 to Cox3) form the catalytic core
(14). The catalytic core is surrounded by nucleus-encoded sub-
units, which confer stability to the holoenzyme and likely pro-
vide sites for the regulation of its activity (25). The fully
assembled yeast holoenzyme is further organized into super-
complexes with the bc1 cytochrome c reductase (22). The cat-
alytic core subunits contain heme and copper redox cofactors
(41). Cox2 binds two copper ions, forming the binuclear CuA
center that is reduced by cytochrome c. Electrons from the
CuA center are transferred to a low-spin heme a center in Cox1
and subsequently to a heterobimetallic heme a-copper site,
designated heme a3:CuB, where molecular oxygen is bound
and reduced to water (3, 45).
The heme a cofactor found in CcO differs from protoheme
in that a hydroxyethylfarnesyl group replaces a vinyl moiety
and a pyrrole methyl group is oxidized to a formyl substituent.
Heme a synthesis is catalyzed by two successive enzymes,
Cox10 and Cox15, that reside within the inner membrane (IM)
(7, 21). Cox10 is a farnesyl transferase that converts protoheme
to heme o. Cox15 subsequently catalyzes the oxidation of the
C-8 heme methyl group in a reaction that involves matrix Yah1
ferredoxin and Arh1 ferredoxin reductase (8, 11). Yeast cells
lacking Cox15 contain no heme a, but show low levels of heme
o, suggesting that the activities of the two enzymes are not
linked (9). Likewise, Cox15 mutations in patients exhibiting
fatal infantile hypertrophic cardiomyopathy result in reduced
heme a but elevated heme o levels (2).
In yeast, CcO biogenesis commences with Cox1 synthesis on
mitochondrial ribosomes tethered to the IM by IM-associated
Pet309 and Mss51 that bind to the 5 untranslated region
(UTR) of the Cox1 transcript (29, 40, 46). Mss51 has a second
function in translational elongation of Cox1, and this function
occurs within high-mass Mss51 complexes (450 and 400
kDa) consisting of Mss51, Cox14, and newly synthesized Cox1
(6, 33, 34). Cox1 appears to progress from the Mss51-contain-
ing complex to downstream transient assembly complexes in-
volving Shy1 (31, 34). Yeast cells contain another Cox1 matu-
ration factor, Coa1, which also forms an 440-kDa Cox1
assembly intermediate (34). The observed interactions of Coa1
with Mss51 and Shy1 suggest that it participates in the early
Cox1 maturation pathway. Information on whether Coa1 is an
integral component of the Mss51- or Shy1-containing Cox1
complexes is lacking.
The heme a3 cofactor center appears to be inserted in Cox1
associated with the Shy1 complex (26, 35). The evidence for
heme a3 site formation within the Shy1 complex is 2-fold. First,
CcO assembly stalled at CuB site formation in Cox1 or at the
downstream maturation of Cox2 results in accumulation of a
transient Cox1 pro-oxidant intermediate that correlates with
the presence of a reactive five-coordinate heme a3 cofactor
(26). The pro-oxidant heme a3:Cox1 intermediate is absent in
cells lacking Shy1, Coa1, or Cox1 (35). Second, isolation of
CcO in Rhodobacter or Paracoccus cells lacking Surf1 (a Shy1
ortholog) reveals an enzyme complex deficient in heme a3 but
not heme a (12, 37). Shy1 is not likely a heme a3-insertase,
since yeast shy1 cells and mutant SURF1 human cells retain
10 to 15% residual CcO activity (17, 36, 47). Rather, Shy1 may
be a Cox1 chaperone stabilizing the heme a3 site during Cox1
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maturation. In the absence of Shy1, it is likely that the heme
a3:Cox1 assembly intermediate is destabilized and only a frac-
tion of the intermediate progresses to the final stages of CcO
maturation.
CuB site formation in Cox1 requires the assembly factor
Cox11. CcO isolated from Rhodobacter sphaeroides cox11
cells lacked CuB but contained both hemes and the CuA site
(23). However, heme a3 showed an altered environment by
electron paramagnetic resonance (EPR) spectroscopy, most
likely due to the absence of the CuB site. Assembly of CcO in
Rhodobacter differs from that in yeast in that the three-subunit
core enzyme can form without heme or Cu cofactors (24). In
contrast, yeast cells lacking Cox11 fail to assemble CcO, and
the stalled assembly complexes are largely removed by prote-
olysis, although residual heme a3:Cox1 intermediates persist in
cox11 yeast cells, resulting in hydrogen peroxide sensitivity
(26).
The heme a center in Cox1 may be formed earlier than the
CuB-heme a3 center. Studies with fibroblasts from patients
with mutant Cox10 or Cox15 reveal limited accumulation of
the free Cox1 subunit (1, 2). In contrast, CcO-deficient patients
with mutations in SURF1 revealed a Cox1 assembly interme-
diate with two nuclear CcO subunits, CoxIV and Va (equiva-
lent to yeast subunits Cox5a and Cox6) (39, 43, 47). One
interpretation of these results is that heme a insertion may be
necessary for formation or stabilization of the S2 intermediate.
In addition, studies of the assembly of the bo3 oxidase of
Escherichia coli revealed that insertion of heme b (analogous to
the heme a site in cytochrome oxidase) was necessary for
subunit assembly (38).
Two goals motivated the present work. First, we sought to
elucidate the interrelationship of the various Cox1 maturation
complexes involving Mss51, Coa1, and Shy1. Second, we
wanted to discern the steps in which the heme a and CuB-heme
a3 cofactor sites are formed during Cox1 maturation in yeast.
We show here that separate Mss51-Cox1, Coa1-Cox1, and
Shy1-Cox1 assembly intermediates exist and that the heme a
and CuB centers are formed downstream of the Mss51-con-
taining and Coa1-containing Cox1 intermediates.
MATERIALS AND METHODS
Yeast strains and vectors. Yeast strains used in this study are described in
Table 1. The chromosomal loci of the respective genes in DY5113 Saccharomyces
cerevisiae were tagged with a 13Myc epitope generated by PCR-based gene
modification using the template pFA6a-13Myc-TRP1, pFA6a-13Myc-HIS3MX6,
or pFA6a-13Myc-KanMX4 (28). The deletion strains were created by disruption
using homologous recombination of KanMX4 or Candida albicans URA3. Proper
integration was confirmed by PCR of the locus. We also used plasmids pRS423-
MSS51 (35), pRS416-SHY1-13Myc, pRS413-SCO1-HA, pHCDW3, pHCDW3-
111, pHCDW3-208, and pHCDW3-210 (15). Plasmid pRS415-COX11-3HA was
obtained by cloning a 1,059-bp XhoI/XbaI COX11-3HA fragment from pRS416-
COX11-3HA (27) into the single-copy expression vector pRS415 under control
of the ADH1 promoter (32).
Cells were cultured in either rich medium or synthetic complete (SC) medium
lacking the appropriate nutrients for plasmid selection. The carbon source used
was either 1% or 2% glucose, 2% glycerol–2% lactate, or 2% raffinose. Yeast
strains were transformed using lithium acetate.
Generation of the Cox1 heme a binding mutant strains. The plasmid pYGT21
carrying the wild-type (WT) intronless sequence of COX1 was kindly provided by
J. Lazowska (CNRS). Mutagenesis was performed using the QuikChange site-
directed mutagenesis kit (Stratagene) according to the manufacturer’s recom-
mendations. After verification of the sequence, the plasmids carrying the mu-
tated genes were used for biolistic transformation. Mitochondrial transformation
of a rho0 recipient strain by microprojectile bombardment and identification of
the mitochondrial transformants were performed as described previously (30)
The mutated genes were then introduced into a rho mitochondrial genome by
recombination by mating the mitochondrial transformants (or synthetic rho)
with CKWT, carrying the wild-type intronless mitochondrial genome and the
nuclear mutation kar1-1, which is required for cytoduction (18). Recombinant
rho colonies with mutated cox1 were identified by crossing with tester strains.
The mutated mitochondrial genomes of these strains were then transferred into
W303-1B/rho0. The resulting strains were used for analysis.
Mitochondrion purification and assays. Intact mitochondria were isolated
from yeast as described previously (19, 20). The total mitochondrial protein
concentration was determined by the Bradford assay (10).
In vivo mitochondrial protein translation assay. The cells were pregrown
overnight in supplemented medium containing 2% raffinose, reinoculated in
complete medium with 2% raffinose, and grown to an optical density at 600 nm
(OD600) of 1. The labeling and preparation of the samples for 12% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) were done as
described previously (34). The gel was dried, and radiolabeled proteins were
visualized by autoradiography.
BN-PAGE. Blue native gel electrophoresis (BN-PAGE) was performed essen-
tially as described previously (44) with slight modifications. Mitochondria (30 to
50 g) were spun down at 12,000  g for 10 min at 4°C. Pellets were solubilized
in lysis buffer (50 mM NaCl, 5 mM 6-aminocaproic acid, 50 mM imidazole, pH
7.0) in the presence of 1% digitonin and protease inhibitors [1 mM 4-(2-amino
ethyl)benzenesulfonyl fluoride and Roche Diagnostics protease inhibitor cock-
tail]. After incubation for 20 min on ice and centrifugation (20,000  g for 15 min
at 2°C) supernatants were mixed with sample buffer (5% Coomassie brilliant blue
G250, 0.5 M 6-aminocaproic acid, pH 7.0) and loaded on a 5 to 13% gradient
polyacrylamide gel. Separated complexes were transferred to a polyvinylidene
fluoride membrane and detected by immunoblotting with appropriate antibod-
ies. For second-dimension SDS-PAGE, lanes were cut out, incubated in 1%
SDS–1% -mercaptoethanol for 1 h at room temperature, run on a 12% SDS
gel, and analyzed by immunoblotting.
Antibody shift native electrophoresis. Antibody shift BN-PAGE was carried
out as described previously (42). Briefly, clarified mitochondrial lysates were
prepared as described above, mixed with 30 to 40 g of either nonspecific
preimmune IgG or anti-Myc antibodies, and incubated at 4°C for 1 h with gentle
agitation. Following the incubation, lysates were reclarified by centrifugation at
20,000  g for 15 min at 2°C, mixed with the sample buffer, and subjected to
BN-PAGE.
Sucrose gradient centrifugation. Mitochondria (1,500 to 2,000 g) were lysed
in 1% digitonin, 20 mM HEPES (pH 7.4), 150 mM KCl, 1.2 mM MgCl2, and 0.5
mM phenylmethylsulfonyl fluoride (PMSF) for 15 min at 4°C. The cleared lysates
(centrifuged for 15 min at 20,000  g and 4°C) were subjected to the antibody
shift as described above, loaded onto continuous 7 to 30% sucrose gradients (5
ml; 20 mM HEPES [pH 7.4], 150 mM KCl, 1.2 mM MgCl2, 0.5 mM PMSF, and
0.1% digitonin), and centrifuged at 148,000  g for 8 h at 2°C. Collected fractions
were analyzed by SDS-PAGE and immunoblotting.
Immunoassays. Immunoprecipitations (IP) were performed as described pre-
viously (34). For immunoblotting, mitochondrial protein was loaded onto a 12%
polyacrylamide gel, separated by SDS-PAGE, and transferred onto a nitrocel-
lulose membrane. Membranes were probed with the indicated primary antibody
and visualized with ECL reagents (Pierce) following incubation with horseradish
peroxidase-conjugated secondary antibodies or with the Odyssey infrared imag-
ing system (Li-Cor Biosciences) with fluorescent secondary antibodies. Anti-Myc
and antihemagglutinin (anti-HA) antibodies were obtained from Roche Diag-
nostics and Molecular Probes; antiporin was from Molecular Probes; and anti-
sera to Cox1, Cox2, and Cox3 subunits were from Mitosciences. We also used
anti-Cox11 antiserum (15). Antiserum to Sod2 was a kind gift from Val Culotta.
Alex Tzagoloff provided antiserum to F1 ATP synthase. Bernard Trumpower
kindly provided antiserum to Rip1.
RESULTS
Early Cox1 maturation complexes. The biogenesis of CcO
commences with Cox1 synthesis on IM-associated mitoribo-
somes. The newly synthesized Cox1 is rapidly captured by a
protein complex containing Mss51 and Cox14 (6, 33, 34).
Blue native polyacrylamide gel electrophoresis (BN-PAGE)
of digitonin-solubilized mitochondria isolated from cells
containing a chromosomally epitope-tagged Mss51 reveals two
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high-mass protein complexes (Fig. 1A, lane 1, complexes A1
and A2) (34). Related high-mass complexes are seen in cells
with chromosomally tagged Coa1 or Shy1 (Fig. 1B and C, lanes
1) (34). The Mss51-containing and Coa1-containing Cox1 com-
plexes are independent of Shy1, as the complexes are present
in greater abundance in shy1 cells (Fig. 1A and B, lanes 3).
Likewise, the A2 Mss51-containing Cox1 complex is enhanced
in abundance in coa1 cells (Fig. 1A). Neither the Coa1 nor
the Shy1 complex is present in cells lacking Mss51 (Fig. 1B and
C, lanes 2). These results are consistent with the Mss51-,
Coa1-, and Shy1-containing Cox1 complexes being distinct en-
tities.
Each of the three complexes contains newly synthesized
Cox1 (34). The Mss51, Coa1, and Shy1 complexes are absent in
the mitochondria lacking Cox1 or its translation activator
Pet309 or in rho0 cells (reference 34 and data not shown). The
three Mss51, Coa1, and Shy1 complexes are dynamic in nature.
Purified mitochondria treated for 30 min with puromycin to
prematurely terminate mitochondrial translation attenuated
each complex (Fig. 1D, E, and F, lanes 2). Neither treatment
attenuated the steady-state levels of the tagged proteins (Fig.
1G). The complexes were also diminished by inhibition of
mitochondrial protein synthesis by a 3-h treatment of the cul-
tures with chloramphenicol (data not shown). These results
suggest that the stability of the high-mass Mss51, Coa1, and
Shy1 complexes is sensitive to changes in Cox1 synthesis and
that they likely represent transient assembly intermediates.
The Mss51, Coa1, and Shy1 complexes were assessed in cells
arrested in CcO maturation at later stages. Cells lacking Cox11
fail to assemble the CuB center in Cox1. The Mss51-containing
and Coa1-containing Cox1 complexes are WT in cox11 cells,
although the Shy1-containing Cox1 complex is markedly atten-
uated (Fig. 2A, B, and C, lanes 2). Although the 450-kDa
Shy1 complex is attenuated, steady-state levels of Shy1 are
normal. A similar situation exists in cells stalled in Cox2 mat-
uration by the deletion of SCO1, resulting in a lack of CuA site
TABLE 1. Yeast strains used in this work
Strain Genotype Referenceor source
W303 MAT	 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1
W303-1B MAT	 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 
i 30
CKWT MATa leu1 kar1-1 30
CW(H62A) MAT	 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 
i 
cox1 (H62A) This study
CW(H376A) MAT	 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 
i 
cox1 (H376A) This study
CW(H62A) SHY1-13Myc MAT	 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 
i 
cox1 (H62A) SHY1-13Myc::HIS3MX6 This study
CW(H376A) SHY1-13Myc MAT	 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 
i 
cox1 (H376A)
SHY1-13Myc::HIS3MX6
This study
CW(H62A) MSS51-13Myc MAT	 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 
i 
cox1 (H62A)
MSS51-13Myc::HIS3MX6
This study
CW(H376A) MSS51-13Myc MAT	 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 
i 
cox1 (H376A)
MSS51-13Myc::HIS3MX6
This study
CW(H62A) COA1-13Myc MAT	 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 
i 
cox1 (H62A) COA1-13Myc::HIS3 This study
CW(H376A) COA1-13Myc MAT	 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 
i 
cox1 (H376A) COA1-13Myc::HIS3 This study
MSS51-13Myc COA1-3HA MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 COA1-3HA::TRP1 MSS51-13Myc::HIS3MX6 34
MSS51-13Myc COA1-3HA cox11 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 COA1-3HA::TRP1 MSS51-13Myc::HIS3MX6
cox11::CaURA3
This study
MSS51-13Myc COA1-3HA sdh2 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 COA1-3HA::TRP1 MSS51-13Myc::HIS3MX6
sdh2::CaURA3
This study
MSS51-13Myc COA1-3HA cox15 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 COA1-3HA::TRP1 MSS51-13Myc::HIS3MX6
cox15::CaURA3
This study
MSS51-13Myc COA1-3HA cox10 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 COA1-3HA::TRP1 MSS51-13Myc::HIS3MX6
cox10::CaURA3
This study
COA1-13Myc MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 COA1-13Myc::HIS3MX6 34
COA1-13Myc cox11 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 COA1-13Myc::HIS3MX6 cox11::CaURA3 This study
COA1-13Myc sdh2 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 COA1-13Myc::HIS3MX6 sdh2::CaURA3 This study
COA1-13Myc shy1 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 COA1-13Myc::HIS3MX6 shy1::CaURA3 This study
COA1-13Myc cox15 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 COA1-13Myc::HIS3MX6 cox15::CaURA3 This study
COA1-13Myc cox10 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 COA1-13Myc::HIS3MX6 cox10::CaURA3 This study
SHY1-13Myc MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 SHY1-13Myc::TRP1 35
SHY1-13Myc COA1-3HA MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 SHY1-13Myc::TRP1 COA1-13Myc::HIS3MX6 35
SHY1-13Myc cox11 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 SHY1-13Myc::TRP1 cox11::HIS3 This study
SHY1-13Myc sco1 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 SHY1-13Myc::TRP1 sco1::CaURA3 This study
SHY1-13Myc sdh2 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 SHY1-13Myc::TRP1 sdh2::CaURA3 This study
SHY1-13Myc cox15 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 SHY1-13Myc::TRP1 cox15::CaURA3 This study
SHY1-13Myc cox10 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 SHY1-13Myc::TRP1 cox10::CaURA3 This study
SHY1-13Myc cox14 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 SHY1-13Myc::TRP1 cox14::CaURA3
COX14-3HA MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 COX14-HA::HIS3MX6 34
COX14-13Myc MSS51-3HA MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 COX14-13Myc::HIS3MX6
MSS51-3HA::TRP1
34
COX14-13Myc COA1-3HA MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 COX14-13Myc::TRP1 COA1-3HA::HIS3MX6 34
cox1::ARG8 m MATa lys2 leu2-3,112 arg8::hisG ura3-52 
cox1::ARG8 m 33
cox1::ARG8 m SHY1-13Myc MATa lys2 leu2-3,112 arg8::hisG ura3-52 
cox1::ARG8 m SHY1-13Myc::KanMX4 This study
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FIG. 1. Cox1 maturation complexes. (A) Mitochondria (30 to 50 g) containing a 13Myc epitope-tagged version of MSS51 were isolated from
wild-type (WT), coa1, and shy1 cells and lysed with 1% digitonin. Clarified lysates were loaded onto a continuous 5 to 13% gradient gel and
subjected to BN-PAGE. The distribution of the respective complexes was analyzed by immunoblotting with anti-Myc antibodies. Anti-F1 serum
was used to visualize the monomeric form of complex V (V), which served as a loading control. (B) COA1-13Myc-tagged mitochondria isolated
from WT, mss51, and shy1 cells, analyzed by native electrophoresis. (C) BN-PAGE analysis of WT, mss51, and coa1 mitochondria containing
Shy1-13Myc. (D to F) Mitochondria (30 to 50 g) were isolated from WT strains expressing MSS51 (D), COA1 (E), and SHY1 (F) genes
endogenously tagged with a 13Myc epitope tag. Isolated organelles were incubated for 30 to 45 min on ice in the presence () or absence () of
puromycin (250 M). Followed incubation, reisolated mitochondria were solubilized and subjected to BN-PAGE. (G) Steady-state levels of the
indicated proteins were assessed by SDS-PAGE in both puromycin-treated () and untreated () mitochondria. Matrix protein Sod2 visualized
by the respective antiserum was used as a loading control.
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formation. The Shy1-containing Cox1 complex is diminished,
whereas the Mss51- and Coa1-containing Cox1 complexes are
normal (Fig. 2A, B, and C, lanes 4). To assess whether the
attenuation of the Shy1-containing Cox1 complex is simply due
to the respiratory deficiency of the cells, we evaluated the three
complexes in respiration-deficient sdh2 cells that lack succi-
nate dehydrogenase (Fig. 2A, B, and C, lanes 6). All three
complexes are present at WT levels. One difference between
respiration-deficient cells with defects in succinate dehydroge-
nase and those with CcO deficiency is that many CcO assembly
mutants result in an attenuation in Cox1 translation (6). As can
be seen in Fig. 2D, sco1 cells show a significant diminution in
newly synthesized Cox1 in the pulse phase of a mitochondrial
translation assay, whereas sdh2 cells show normal Cox1 lev-
els. The diminution in Shy1-containing Cox1 complex levels in
cox11 and sco1 cells may arise from diminished newly syn-
thesized Cox1 levels caused by decreased translation (6) as well
as enhanced degradation. Assessment of Cox1 translation by
monitoring expression of a Cox1-Arg8 fusion in shy1 cells
revealed WT translation (33), so the reduced Cox1 levels in
cox11 and sco1 cells may arise in part from facilitated Cox1
degradation.
To further clarify the interrelationship of the three Cox1
assembly complexes, we conducted a series of antibody shift
FIG. 2. The Shy1 complex is affected in CcO assembly mutants. Mitochondria were prepared from the wild-type (WT), cox11, sco1, and
sdh2 strains with the genomically tagged versions of the respective proteins and analyzed by BN-PAGE as described for Fig. 1. (A to C)
Distributions of Mss51-Myc (A), Coa1-Myc (B), and Shy1-Myc (C) complexes in cox11, sco1, and sdh2 mitochondria. (D) In vivo labeling of
mitochondrial translation products. WT, sco1, and sdh2 cells were pulsed for 15 min with [35S]methionine at 30°C. The reaction was stopped
by addition of cold methionine, and samples were analyzed by 12% SDS-PAGE followed by autoradiography.
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studies using BN-PAGE. Specifically, mitochondria isolated
from cells containing dually tagged CcO assembly factors were
solubilized with digitonin and fractionated by two-dimensional
BN-PAGE. Two-dimensional analysis was required since the
HA epitope tag was poorly visible upon immunoblotting of
one-dimensional gels. In each case, anti-Myc monoclonal an-
tibodies were used to shift one chromosomally tagged factor
and the position of the HA-tagged protein was assessed in the
second SDS-PAGE dimension (Fig. 3). Mss51, Coa1, and Shy1
are all known to form lower-mass components (the B com-
plexes seen in Fig. 1 and 2), so antibody shifts will also result
in retardation of these components. As a positive control, we
evaluated the interaction of Cox14 and Mss51, which is well
established (6). Anti-Myc antibodies yield a dramatic mobility
shift of Cox14-Myc, resulting in a corresponding shift in
Mss51-HA, whereas no shift in either is seen with nonspecific
antibodies (Fig. 3A). To address the putative interaction of
Mss51 and Coa1, Mss51-Myc and Coa1-HA mitochondrial ly-
sates were fractionated (Fig. 3B). The addition of anti-Myc
antibodies yields a clear shift of Mss51, but only a small frac-
tion of Coa1-HA is shifted. This observation is consistent with
the above-mentioned WT Mss51-containing Cox1 complexes
FIG. 3. Antibody gel shift BN studies. Mitochondria (0.3 mg) from yeast strains coexpressing COX14-Myc and MSS51-HA (A), MSS51-Myc and
COA1-HA (B), COX14-Myc and COA1-HA (C), SHY1-Myc and COA1-HA (D), COX14-HA and SHY1-Myc (E), and MSS51-HA and SHY1-Myc
(F) were solubilized with 1% digitonin, and clarified lysates were incubated with either nonspecific preimmune (p.i.-IgG) or anti-Myc antibodies
for 60 min on ice. Followed the incubation, reclarified lysates were separated by native electrophoresis in the first dimension and SDS-PAGE in
the second dimension and analyzed by Western blotting.
VOL. 30, 2010 ASSEMBLY OF REDOX COFACTORS IN Cox1 1009
in coa1 cells (Fig. 1A). Whereas Cox14 is clearly a component
of the Mss51-containing Cox1 complex, Cox14 does not appear
to be a stable component of the Coa1 complex (Fig. 3C) or the
Shy1-containing Cox1 complex (Fig. 3E). Likewise, despite a
weak interaction of Coa1 and Shy1 seen by co-IP (34), anti-
body shifting of the Shy1-containing Cox1 complex did not
result in a coshift of Coa1 (Fig. 3D). Finally, Mss51 and Shy1
were reported to interact (31, 34), but antibody shifting of the
Shy1 complex failed to shift Mss51 (Fig. 3F). This last obser-
vation is consistent with a second co-IP study that failed to
detect a Mss51/Shy1 interaction (5).
The antibody shift experiment was also evaluated by sucrose
density gradient fractionation (Fig. 4). The coshifting of Mss51
and Cox14 was corroborated as a positive control (Fig. 4A).
The independence of the Cox14, Coa1, and Shy1 complexes
was corroborated, as antibody shifting of Cox14 had minimal
effect on Coa1 (Fig. 4B) or Shy1 (Fig. 4C). The shifting of
Cox14 also did not appear to perturb assembled CcO within a
bc1:CcO supercomplex as marked by Cox2. Thus, the reported
presence of Cox14 in the supercomplexes (31) needs further
verification.
The antibody shift experiments support the postulate that
three separate newly synthesized Cox1 maturation complexes
exist. The first complex consists of Mss51 and Cox14. The
Coa1-containing Cox1 complex is distinct from the Mss51- or
the Shy1-containing complexes. We next sought to assess
whether the Cox1 present in either the Mss51, Coa1, or Shy1
assembly intermediate complexes contained the redox cofac-
tors.
Effect of Cox10 on early Cox1 maturation complexes. Cox1
maturation involves the addition of two heme a cofactors and
the formation of a mononuclear CuB center. Cox1 consists of
12 transmembrane helices organized in six successive helical
pairs forming a closed bundle. The heme a site farnesyl tail is
packed between helices 1,11, and 12. The axial His ligands for
heme a are His-62 in helix 2 and His-378 in helix 10. Thus,
heme a binding may be important to stabilize the Cox1 helical
bundle. We took two approaches to assess whether the Mss51,
Coa1, and Shy1 complexes were influenced by heme a cofactor
insertion into Cox1. First, we tested whether the Mss51, Coa1,
and Shy1 complexes formed in cells lacking Cox10. The second
approach focused on related complexes in mutant Cox1 strains
with substitutions at heme a axial His ligands.
In the first approach, the COX10 locus was deleted in cells
with tagged Mss51-Myc, Coa1-Myc, or Shy1-Myc. Mitochon-
dria were isolated from the tagged cox10 strains and sub-
jected to BN-PAGE. As can be seen in Fig. 5A, the two high-
mass A1/A2 Mss51 complexes were intact in cells lacking
Cox10. Coa1-Myc cells lacking Cox10 exhibited a WT Coa1
BN complex (Fig. 5A). In contrast, loss of Cox10 had a pro-
found effect on the Shy1 complex. Cells containing Shy1-Myc
but lacking Cox10 fail to show the high-mass Shy1 BN complex.
The absence of Cox10 does not attenuate the level of Shy1 in
yeast as assessed by SDS-PAGE (Fig. 5B). The lack of pertur-
bation of Mss51 or Coa1 complexes in cells lacking Cox10
suggests that either the Coa1- and Mss51-containing Cox1
complexes lack the two heme a centers or, alternatively, heme
a binding is not critical for the stability of these complexes. In
contrast, the Shy1-Myc BN complex is sensitive to the absence
of Cox10.
FIG. 4. Antibody gel shift sucrose gradients. Mitochondria (1.5 to 2
mg) from yeast strains coexpressing COX14-Myc and MSS51-HA (A),
COX14-Myc and COA1-HA (B), and COX14-HA and SHY1-Myc
(C) were lysed with 1% digitonin, and clarified lysates were incubated
with the respective antibodies as described for Fig. 3. Followed the
incubation, reclarified lysates were loaded onto continuous 7 to 30%
sucrose gradients and subjected to high-velocity centrifugation. Frac-
tions were collected and analyzed by SDS-PAGE and immunoblotting.
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Since Cox1 translation is impaired in cox10 cells (6), the
attenuation in the Shy1 BN complex may arise merely from
reduced Cox1 levels. Overexpression of MSS51 reverses the
Cox1 translation block in CcO assembly mutants (4, 6). Ele-
vated Mss51 levels in cox10 cells restored Cox1 translation
(Fig. 5C), but restoration of newly synthesized Cox1 levels did
not restore the high-mass Shy1 complex (Fig. 5D). Thus, the
destabilization of the Shy1 complex may relate to the absence
of the heme a in Cox1.
Effect of perturbation of heme a binding sites in Cox1 on
assembly intermediates. A second strategy to assess the role of
heme a in the early Cox1 subassembly complexes was to assess
formation of Mss51, Coa1, and Shy1 assembly complexes in
cells containing mutant alleles of Cox1 in which the axial heme
a ligands were mutated. One of the two His ligands of the
heme a site (His-62) and the single axial His-376 ligand of the
heme a3 site were each changed to Ala. The two resulting
mutant Cox1 strains were respiration deficient and steady-state
levels of CcO subunits were attenuated, consistent with the
lack of CcO activity (Fig. 6A and B). The newly synthesized
Cox1 was markedly attenuated in the mitochondrial translation
assay, although limited levels were present (Fig. 6C). Dimeric
complex III and monomeric complex V were intact in the
mutant cells, also suggesting that the mitochondrial genome
was intact (data not shown). Chromosomal Myc epitope tags
were engineered into MSS51, COA1, and SHY1 loci, generat-
ing C-terminally Myc-tagged molecules in the cox1 mutant
strains. Detergent-solubilized mitochondrial lysates from each
strain were subjected to BN-PAGE (Fig. 6D). Whereas both
strains showed the normal A1/A2 Mss51 and Coa1 complexes,
the Shy1 complexes were barely detectable in the H62A cox1
mutant and were attenuated in the H376A mutant. However,
steady-state levels of Shy1 were normal (Fig. 6F). In repeated
analyses of the abundance of the Shy1 BN complex, the level
was markedly attenuated in cells with the H62A Cox1 mutant
(Fig. 6E). We conclude that the failure to bind heme a in either
cofactor site in Cox1 has no apparent effect on the high-mass
Mss51 and Coa1 complexes but results in a destabilization of
the Shy1 complexes.
Formation of the CuB site in Cox1 maturation. If Shy1 is a
Cox1 chaperone stabilizing the heme a3 center, the prediction
is that the Shy1-containing Cox1 complex may be the interme-
diate in which the CuB site is formed, leading to the heterobi-
metallic CuB-heme a3 center. The only CuB-specific assembly
factor known to date is the Cu(I) binding Cox11 protein teth-
ered to the IM by an N-terminal transmembrane domain. To
assess whether Cox11 interacts with Shy1, we performed a
series of co-IP studies with epitope-tagged Shy1-Myc and
Cox11-HA. Both tagged proteins are fully functional in medi-
ating CcO assembly. Immunoprecipitation of Cox11 led to the
co-IP of limited quantities of Shy1 (Fig. 7A). Limited interac-
tion also occurred in the reciprocal IP (Fig. 7B), and no non-
specific bead binding was observed (Fig. 7C). Whereas Cox11
showed a co-IP with Shy1, no such interaction was observed
between Shy1 and the CuA metallochaperone Sco1 or between
Cox11 and Sco1 (data not shown). Cox11 was also found to
partially interact with Coa1 by IP (Fig. 7D), and this interac-
tion persisted in the absence of Shy1 (Fig. 7E). To assess
FIG. 5. Cox1 assembly intermediates in cells compromised in heme a synthesis. (A) Lysates from wild-type (WT) or cox10 mitochondria with
genomically tagged Mss51-Myc, Coa1-Myc, or Shy1-Myc were subjected to BN-PAGE, and the distribution of the respective complexes was
analyzed by immunoblotting as described for Fig. 1. (B) The steady-state levels of Shy1-Myc were assessed as described for Fig. 1. (C) In vivo
labeling of mitochondrial translation products in SHY1::Myc cox10 cells expressing either empty vector or COX10 or overexpressing MSS51. Cells
were treated and analyzed as for Fig. 2D. (D) Distribution of Shy1-Myc complexes in SHY1::Myc cox10 cells carrying either COX10 or empty
vector or overexpressing MSS51, analyzed by native electrophoresis.
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whether the Cox11 interactions with Shy1 and Coa1 led to
stable complexes, antibody gel shift studies were performed.
Anti-Myc antibodies successfully shifted Shy1-Myc on BN-
PAGE, and limited amounts of Cox11-HA were shifted (Fig.
7F). Similar antibody shift experiments with Coa1-Myc and
Cox11-HA mitochondrial detergent lysates revealed no appre-
ciable modulation of Cox11 (Fig. 7G). These experiments sug-
gest that Cox11 may transiently associate with the Shy1-con-
taining and Coa1-containing Cox1 complexes, but Cox11 is not
an integral component of either complex.
To assess whether the observed Cox11/Shy1 interaction was
dependent on Cox1, we tested whether the interaction per-
sisted in mitochondria treated with puromycin to prematurely
terminate mitochondrial translation. The 30-min puromycin
treatment abrogated the Cox11/Shy1 interaction (Fig. 8A), al-
though the treatment did not alter the steady-state levels of
either protein (Fig. 8B). The Cox11/Shy1 interaction was not
evident in mitochondria from cox1 cells (Fig. 8C) or in cells
lacking Cox14 that fail to form either the Coa1- and Shy1-
containing Cox1 complexes (data not shown). The Cox11/Shy1
interaction was also attenuated in cells harboring the mutant
Cox1 alleles, especially the H62A Cox1 mutant (Fig. 8D
and E).
Involvement of Cox11 in stabilization of the Shy1-Cox1 com-
plex. The 450-kDa Shy1 complex is unstable in cells lacking
Cox11. To assess whether the Shy1 complex was dependent on
a functional Cox11, we tested three mutant alleles of Cox11
with Cys substitutions. We reported previously that C111A,
C208A, and C210A substitution in yeast Cox11 resulted in a
CcO deficiency. Cys208 and Cys210 are two Cu(I) binding
residues (15). The respiratory deficiency of cells containing
these mutant Cox11 alleles is shown in Fig. 9A. The mutant
proteins accumulate to normal levels (Fig. 9B). BN-PAGE of
detergent lysates of mitochondria isolated from mutant Cox11
cells showed that the marked attenuation of the 450-kDa
Shy1 complex in cox11 cells was reversed by the introduction
of WT COX11 (Fig. 9C). Residual Shy1 complexes were evi-
dent in cells containing the nonfunctional C208A or C210A
Cox11 mutant. In contrast, no enhanced Shy1 complex is seen
with a C111A Cox11 mutant. It is not clear whether Cys111 is
involved in Cu(I) binding or Cox11 dimer formation (4, 15).
Thus, formation of the Shy1-containing Cox1 complex is not
strictly dependent on a functional Cox11. As mentioned, the
450-kDa Shy1 complex may be influenced by the level of
Cox1 translation. We tested whether overexpression of MSS51
in cox11 cells would restore a normal Shy1 complex. Al-
FIG. 6. Cox1 assembly intermediates in cells compromised in heme a coordination. (A) Respiratory growth of cox1 heme-binding mutants.
Cells were pregrown in complete liquid medium, serially diluted, and spotted onto plates containing 2% glucose or glycerol/lactate as a carbon
source. (B) Steady-state levels of Cox1 to -3 subunits as well as Rip1 were assessed in mitochondria (80 g) from the WT or cox1 H62A and cox1
H376A mutants. The outer mitochondrial membrane porin served as a loading control. (C) In vivo labeling of mitochondrial translation products.
WT, cox1 H62A, and cox1 H376A cells were pulsed for 15 min with [35S]methionine at 30°C. The reaction was stopped by addition of cold
methionine. Followed a 90-min chase at 30°C, samples were subjected to SDS-PAGE and analyzed by autoradiography. The asterisk designates
an unidentified translation product. (D) WT, cox1 H62A, and cox1 H376A mitochondria with endogenously tagged Mss51-Myc, Coa1-Myc, and
Shy1-Myc were analyzed by BN-PAGE. (E) Bar graph showing abundance (normalized to the monomeric ATPase level using ImageJ software)
of Shy1 BN complexes in the WT and the cox1 H62A and cox1 H376A mutants (error bars indicate standard deviations; n  3). (F) Steady-state
levels of Mss51-Myc and Shy1-Myc were assessed as described for Fig. 1.
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though high Mss51 levels increase Cox1 translation seen in the
pulse phase of a translation assay (Fig. 9E), the Shy1 complex
was not restored in cox11 cells (Fig. 9D, lane 3). Therefore,
formation of the Shy1-containing complex is dependent on
numerous factors that stabilize newly synthesized Cox1, includ-
ing Cox11.
DISCUSSION
Cox1 maturation initiates CcO biogenesis. In mitochondrial
genomes sequenced to date, Cox1, Cox2, and Cox3 are com-
monly mitochondrially encoded. However, Cox1 is the only
universally encoded mitochondrial subunit of CcO, with one
example being chlamydomonads, which contain only Cox1 of
CcO subunits (13). The presence of COX1 in the mitochon-
drial genome enables a rapid biosynthetic response to a CcO
deficiency. Newly synthesized Cox1 is captured in early high-
mass assembly intermediates containing Mss51 and Cox14 (6,
33, 34). Cox1 maturation appears to involve a progression from
the Mss51 complex to two downstream assembly intermediates
involving Coa1 and Shy1 (31, 34). All three complexes are
dependent on newly synthesized Cox1 and are abrogated in
mitochondria treated with puromycin. The three steady-state
Cox1 assembly complexes are distinct components in the Cox1
FIG. 7. Analysis of the Cox11 interactome. (A) Mitochondria (0.45 mg) from Shy1-Myc wild-type cells transformed with an empty vector or
Cox11-HA-expressing plasmid were solubilized in buffer containing 1% digitonin, and clarified extracts were immunoprecipitated with goat
polyclonal anti-HA beads. The load, representing 1% of the total fraction and the entire fractions of the last wash and bead eluate, as well as the
fraction of the unbound material (1%) were analyzed by immunoblotting with the respective antibodies. (B) Mitochondrial lysates from Shy1-Myc
wild-type cells transformed with an empty vector or Cox11-HA-expressing plasmid were solubilized, immunoprecipitated with goat polyclonal
anti-Myc beads, and analyzed as described for panel A. (C) Mitochondria from untagged wild-type cells transformed with Cox11-HA-expressing
plasmid were lysed and immunoprecipitated with anti-Myc beads as described for panel B. (D) Mitochondria isolated from Coa1-Myc wild-type
cells expressing episomal Cox11-HA were lysed, immunoprecipitated with anti-HA beads, and analyzed as described for panel B. (E) Lysates from
Coa1-Myc shy1 mitochondria containing Cox11-HA were immunoprecipitated and analyzed as described above. (F) Mitochondria (0.3 mg) from
Shy1-Myc cox11 cells transformed with Cox11-HA-expressing plasmid were solubilized in buffer containing 1% digitonin, and clarified extracts
were subjected to an antibody shift followed by two-dimensional BN-PAGE/SDS-PAGE analysis as described for Fig. 3. (G) Mitochondrial lysates
from Coa1-Myc wild-type cells expressing episomal Cox11-HA were subjected to antibody shift native electrophoresis, followed by SDS-PAGE
separation in the second dimension as described for Fig. 3.
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maturation process. This conclusion is based on two lines of
evidence. First, the two high-mass Mss51- and 440-kDa
Coa1-containing Cox1 complexes persist and actually accumu-
late in cells lacking Shy1. The Mss51 and Coa1 complexes are
therefore upstream of the Shy1 complex. The two high-mass
Mss51 complexes are also stable in cells lacking Coa1, suggest-
ing that they are upstream of the Coa1 complex. Second, an-
tibody shift experiments confirm the three separate Cox1-con-
taining complexes. The high-mass Mss51 complexes are
independent of Shy1 but contain Cox14. A minor fraction of
Mss51 associates with Coa1. The only BN complex that con-
tains Cox14 is the high-mass Mss51 complex(es). The 440-
kDa Coa1-containing Cox1 complex does not contain signifi-
cant levels of Shy1 or Cox14. The Coa1-containing complex
fails to form in cells lacking Cox14 (34). This is rational, as
Cox14 is upstream within the Mss51 complex.
The conclusion that separate Cox1 complexes exist with
Mss51, Coa1, or Shy1 as components is complicated by the
observed copurification or co-IP results showing interactions
between Mss51 and Shy1 (31, 34) and by the observation that
Coa1 interacts with Mss51, Cox14, and Shy1 (31, 34). These
weak interactions may suggest that the separate Cox1 assembly
intermediates transiently interact or that the BN procedure
destabilizes these interactions. Destabilization by the BN pro-
cedure is unlikely, as we fail to see Cox14 interacting with
either Coa1 or Shy1 by antibody shift studies using sucrose
density gradients. Cox1 maturation from the Mss51-containing
complexes may involve Coa1 binding, thereby inducing pro-
gression to the next assembly intermediate. Likewise, progres-
sion from the Coa1-containing Cox1 complex may involve the
Shy1-induced progression to the high-mass Shy1-dominated
complex. This situation may yield the observed transient inter-
actions of Coa1 and Mss51 as well as Coa1 and Shy1. These
transient interactions are depicted in the scheme shown in
Fig. 10.
We show here that the two heme a cofactors are likely added
to Cox1 within or near the high-mass Shy1 complex and not the
early Mss51 or Coa1 assembly intermediates. The evidence for
this conclusion is 2-fold. First, the high-mass Mss51 and Coa1
complexes are unaffected in cells lacking Cox10 that generates
heme o from heme b. In contrast, the high-mass Shy1 BN
complex is attenuated when COX10 is deleted. Stimulation of
Cox1 translation through overexpression of MSS51 does not
restore the Shy1 complex. Second, Cox1 mutants with Ala
substitutions of axial His ligands to heme a and a3 show WT
Mss51 and Coa1 BN complexes, whereas the Shy1 complex was
markedly perturbed in cells containing a mutant Cox1 lacking
the His62 axial heme a ligand. Since the heme a cofactor
appears to have a stabilization role in the Cox1 helical bundle,
we conclude that the heme a site in Cox1 is populated not in
FIG. 8. Cox11 interaction with Shy1 depends on the translation and early maturation of Cox1. (A) Mitochondria prepared from untreated
Shy1-Myc wild-type cells expressing Cox11-HA cells were incubated for 30 to 45 min on ice in the presence of puromycin (250 M) or were mock
treated. Followed the incubation, mitochondria were solubilized in buffer containing 1% digitonin and clarified extracts were immunoprecipitated
with anti-HA beads and analyzed as for Fig. 6. (B) Equal amounts of each type of mitochondria used in IP experiment were subjected to
SDS-PAGE and analyzed by Western blotting with the indicated antibodies. (C) Lysates from Shy1-Myc cox1 mitochondria containing Cox11-HA
were immunoprecipitated with anti-HA beads and analyzed as described above. (D) WT, cox1 H62A, and cox1 H376A mitochondria with
endogenously tagged Shy1-Myc and Cox11-HA were solubilized and immunoprecipitated with anti-Myc beads. (E) Bar graph showing normalized
levels of immunoprecipitated Shy1-Myc and Cox11-HA in the WT and the cox1 H62A and cox1 H376A mutants (error bars indicate standard
deviations; n  3).
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the Mss51 or Coa1 complexes but in the downstream Shy1-
containing complex or in the transition to the Shy1 complex.
Our assumption that heme a has a structural role in Cox1
stabilization may not be true if the Cox1 conformer within the
Mss51 complex is significantly different from that in the mature
Cox1. However, the most likely interpretation of the present
data is that both heme a cofactor sites are populated in Cox1
during the Shy1-associated phase of Cox1 maturation. Forma-
tion of the two heme a centers may occur stepwise, with the
heme a site being populated in a transition to the Shy1-con-
taining complex whereas the heme a3 center may be populated
within the Shy1 complex. This would be consistent with studies
of R. sphaeroides cells lacking the Shy1 homolog Surf1, which
showed a selective depletion of heme a3 (12, 37). Alternatively,
both heme a centers may be populated within the Shy1 com-
plex, but in the absence of Shy1 only the heme a3 center with
a single axial ligand is labile.
We demonstrated previously that formation of the heme a3
center is dependent on Shy1 (35). The heme a3 center does not
appear to have the same major structural effect on Cox1. This
may account for the presence of the residual Shy1 BN complex
in the Cox1 mutant lacking the heme a3 single axial His. Mu-
tations that stall CcO assembly at later steps, such as matura-
tion of the CuA site, result in hydrogen peroxide sensitivity of
the mutant cells (26). The hydrogen peroxide sensitivity arises
from a transient heme a3:Cox1 pro-oxidant intermediate. Shy1
appears to be important for the stability of this assembly in-
termediate. Shy1 is not absolutely required for this step, since
cells lacking Shy1 have residual assembled and active CcO.
CuB site formation also appears to involve the Shy1-contain-
ing Cox1 assembly intermediate. The CuB metallochaperone
Cox11 interacts with Shy1 by co-IP but does not form a stable
complex. The 450-kDa Shy1-containing Cox1 complex is
markedly attenuated in cells lacking Cox11 but is partially
FIG. 9. Role of Cox11 in formation of the high-mass Shy1-containing Cox1 intermediate. (A) Respiratory growth of SHY1::Myc cox11 cells
carrying wild-type COX11 or mutant versions of it. Cells were handled and tested as for Fig. 5C. (B) Steady-state levels of Cox11, Shy1-Myc, and
porin in the transformants, analyzed by SDS-PAGE as described above. (C) BN-PAGE analysis of Shy1 complexes in cox11 cells transformed
with either the COX11 gene or its mutant forms was performed as described above. (D) Distribution of Shy1-Myc complexes in SHY1::Myc cox11
cells carrying either COX11 or empty vector or overexpressing MSS51, analyzed by native electrophoresis. (E) In vivo labeling of mitochondrial
translation products in SHY1::Myc cox11 cells expressing either empty vector or COX11 or overexpressing MSS51. Cells were treated and
analyzed as described for Fig. 6C.
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restored with a nonfunctional Cox11 mutant compromised in
Cu(I) binding. An antibody-induced mass shift in the Shy1
complex shows a partial gel shift in Cox11, suggesting that the
two proteins transiently interact. Thus, formation of the het-
erobimetallic CuB-heme a3 site likely occurs in the Shy1-con-
taining Cox1 complex. The observed Cox11/Shy1 interaction is
dependent on the presence of Cox1 and is attenuated in Cox1
heme a/a3 site mutants. The formation of the CuB-heme a3 site
within the Shy1-containing Cox1 intermediate is supported by
the observation that accumulation of the nonfunctional CcO
complexes in Rhodobacter and Paracoccus surf1 cells is com-
promised in both CuB and heme a3 (12, 37).
The stability of the Shy1-containing Cox1 complex is depen-
dent on numerous factors. First, the complex is attenuated in
cells with mutant Cox1 alleles and is absent in cells lacking
Cox1. Second, the complex is destabilized in cells devoid of
either Cox11 or Sco1 and is not restored by merely enhancing
Cox1 translation. Thus, Cox11 has a stabilizing role in the
maintenance of the important Shy1 complex. The destabiliza-
tion of the Shy1 complex in sco1 cells awaits further investi-
gation but may be related to enhanced proteolysis.
Formation of the CuB site in Cox1 within the Shy1-contain-
ing Cox1 complex is linked to our earlier observation that cells
lacking Shy1 or Coa1 are attenuated in mitochondrial copper
levels (16). We postulate that Cox1 maturation through the
Coa1 and Shy1 complexes is linked to the translocation of
copper from the matrix copper pool to the intermembrane
space (IMS) for Cox11-mediated formation of the CuB site.
The Coa1-containing Cox1 complex may be a signaling com-
plex for Cu(I) translocation. The precise function of the high-
mass Mss51 complexes remains unclear.
In summary, we postulate that Cox1 maturation initiates
with an early Cox1 assembly intermediate containing Mss51
and Cox14 (Fig. 10). This may represent a reservoir of Cox1
poised for CcO biogenesis. This complex does not appear to
have the cofactor sites populated. This may be a favorable state
of Cox1, as it would preclude any deleterious oxidative damage
from the presence of solvent-accessible heme a3. When a need
for additional CcO exists, a signaling event may induce the
progression of Cox1 from the reservoir Mss51 complex to
downstream complexes containing Coa1 and Shy1. Within the
Shy1 complex, the heme a3:CuB site center is formed, although
it remains unclear whether the heme a site is populated within
the Shy1 complex or just prior to that step. These steps are
likely concurrent with the addition of the Cox5a and Cox6
subunits. Upon completion of these steps, Cox1 is likely com-
petent to receive Cox2 and the additional CcO subunits. Fu-
ture studies will address the maturation steps downstream of
the Shy1 complex.
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